Papyrus Therapeutics, Inc. an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer. Co-founded by Professor Hani Gabra, co-founder and CSA, is an internationally recognized leader in ovarian cancer and translational medical oncology. He has over 200 publications and 20,000 citations with an Hirsch Index of 64 And by Dr. Paul Blake, co-founder and CEO, has over 30 ye...
Papyrus Therapeutics, Inc. an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer. Co-founded by Professor Hani Gabra, co-founder and CSA, is an internationally recognized leader in ovarian cancer and translational medical oncology. He has over 200 publications and 20,000 citations with an Hirsch Index of 64 And by Dr. Paul Blake, co-founder and CEO, has over 30 years drug development and multiple NDA/MAA approvals working for Zeneca (now AZ), SB (now GSK), Cephalon (now Teva), Oxford BioMedica and Heron Therapeutics.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.